MediPharm Labs Balance Sheet Health
Financial Health criteria checks 6/6
MediPharm Labs has a total shareholder equity of CA$53.0M and total debt of CA$2.1M, which brings its debt-to-equity ratio to 4%. Its total assets and total liabilities are CA$63.9M and CA$10.9M respectively.
Key information
4.0%
Debt to equity ratio
CA$2.11m
Debt
Interest coverage ratio | n/a |
Cash | CA$18.25m |
Equity | CA$53.01m |
Total liabilities | CA$10.93m |
Total assets | CA$63.94m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MEDI.F's short term assets (CA$36.6M) exceed its short term liabilities (CA$10.9M).
Long Term Liabilities: MEDI.F's short term assets (CA$36.6M) exceed its long term liabilities (CA$69.0K).
Debt to Equity History and Analysis
Debt Level: MEDI.F has more cash than its total debt.
Reducing Debt: MEDI.F's debt to equity ratio has reduced from 21.5% to 4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MEDI.F has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: MEDI.F has sufficient cash runway for 1.3 years if free cash flow continues to grow at historical rates of 7.2% each year.